Lb Pharmaceuticals (LBRX) Other Non-Current Assets (2024 - 2026)

Lb Pharmaceuticals has reported Other Non-Current Assets for 3 years, with the latest figure at $776000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets changed N/A year-over-year to $776000.0; the trailing twelve-month figure through Mar 2026 stood at $776000.0 (changed N/A YoY), and the FY2025 full-year result was $770000.0, up 54.62% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $776000.0, up from $770000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $776000.0 in Q1 2026, with the low at $498000.0 in Q4 2024.
• Average Other Non-Current Assets over 3 years is $639000.0, with a median of $641000.0 recorded in 2025.
• Peak annual rise in Other Non-Current Assets reached 54.62% in 2025, while the deepest fall reached 54.62% in 2025.
• Tracing LBRX's Other Non-Current Assets over 3 years: stood at $498000.0 in 2024, then surged by 54.62% to $770000.0 in 2025, then gained by 0.78% to $776000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $776000.0 (Q1 2026), $770000.0 (Q4 2025), and $512000.0 (Q3 2025), per Business Quant data.

Peer Comparison